PSEUDOMONAS AERUGINOSA
Clinical trials for PSEUDOMONAS AERUGINOSA explained in plain language.
Never miss a new study
Get alerted when new PSEUDOMONAS AERUGINOSA trials appear
Sign up with your email to follow new studies for PSEUDOMONAS AERUGINOSA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaled therapy targets tough lung infections in cystic fibrosis
Disease control Recruiting nowThis study tests an experimental inhaled drug called RSP-1502 in people with cystic fibrosis who have a chronic lung infection from Pseudomonas bacteria. The goal is to check the drug's safety and how the body processes it. About 72 participants aged 12 and older will receive eit…
Matched conditions: PSEUDOMONAS AERUGINOSA
Phase: PHASE1, PHASE2 • Sponsor: Respirion Pharmaceuticals Pty Ltd • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Could patient antibodies beat superbug infections?
Knowledge-focused Recruiting nowThis study looks at 30 patients who have had a Pseudomonas aeruginosa infection or carry the bacteria. The goal is to find and copy the antibodies their bodies made to fight it. These lab-made antibodies could one day offer a new way to treat infections that don't respond to anti…
Matched conditions: PSEUDOMONAS AERUGINOSA
Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated May 17, 2026 05:19 UTC
-
New study seeks best weapon against superbug pseudomonas
Knowledge-focused Recruiting nowThis study looks at 600 adults with difficult-to-treat Pseudomonas infections to see which antibiotic works best. Researchers will compare newer drugs like cefiderocol with older ones like colistin. The goal is to find the most effective treatment and improve patient outcomes.
Matched conditions: PSEUDOMONAS AERUGINOSA
Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Gut germs turn deadly in ICU: scientists watch them change
Knowledge-focused Recruiting nowThis study looks at why a common gut bacterium, Pseudomonas aeruginosa, becomes deadly in critically ill patients. Researchers will collect stool samples from 100 ICU patients to see how the gut environment triggers the bacteria to turn on their virulence genes. The goal is to un…
Matched conditions: PSEUDOMONAS AERUGINOSA
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated May 04, 2026 16:23 UTC